Design of potent PPARα agonists

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

Computational analysis of the ligand binding pocket of the three PPAR receptor subtypes was utilized in the design of potent PPARalpha agonists. Optimum PPARalpha potency and selectivity were obtained with substituents having van der Waals volume around 260. Compound 6 had a PPARalpha potency of 0.002 microM and a selectivity ratio to PPARgamma and PPARdelta of 410 and 2000, respectively.

Knowledge Graph

Similar Paper

Design of potent PPARα agonists
Bioorganic & Medicinal Chemistry Letters 2007.0
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification
Bioorganic & Medicinal Chemistry Letters 2011.0
Design and Structural Analysis of Novel Pharmacophores for Potent and Selective Peroxisome Proliferator-activated Receptor γ Agonists
Journal of Medicinal Chemistry 2009.0
Design, Synthesis, and Structure–Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists
ACS Medicinal Chemistry Letters 2023.0
Structure–activity relationships of dimeric PPAR agonists
Bioorganic & Medicinal Chemistry Letters 2005.0
Large Dimeric Ligands with Favorable Pharmacokinetic Properties and Peroxisome Proliferator-Activated Receptor Agonist Activity in Vitro and in Vivo
Journal of Medicinal Chemistry 2003.0
New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of New Chiral Fibrates with PPARα and PPARγ Agonist Activity
Journal of Medicinal Chemistry 2005.0
Molecular determinants for nuclear receptors selectivity: Chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists
European Journal of Medicinal Chemistry 2013.0
Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method
Bioorganic & Medicinal Chemistry Letters 2022.0